Ivologist Review

What Ivologist charges

• Tirzepatide: $199/mo — the bottom of a $199-$349 per-month range the seller publishes about itself in a blog comparison table, not on a product page; no product page here carries a figure at all

Ivologist also sells 2 compounds this site boards without publishing a price for them: Sermorelin and NAD+.

The price is in a blog post

Its programme pages describe eligibility, clinician review and delivery, and carry no figures at all.

A blog post comparing weight-loss approaches carries a table with a row naming this seller and a per-month range, and the prose above the table repeats it.

That is a self-scoped figure, so it is recorded — but it is recorded as what it is: a range in an article, not a rate on a product page.

The rest of the figures are about other people

The same table prices branded weight-loss drugs, commercial weight programmes, personal training and bariatric surgery.

None of those is this seller's price, and none is filed against it. A market figure in a seller's blog is a claim about the market.

Reading such a table as a price list is one of the easier ways to publish a wrong number, which is why only the row naming this seller was taken.

What it does say about its supply

It says compounded medications, if prescribed, are not FDA-approved.

It names the pharmacy categories it works with rather than saying only that they are licensed, and states that eligibility is determined by licensed providers through a medical evaluation.

It does not name a specific pharmacy, and no state list is published.

Two peptides with no price at all

Sermorelin and NAD+ both appear on its pages as therapies it offers.

Neither carries a figure anywhere read, on a programme page or in an article.

So this seller sits on this roster with a wide menu, one range, and no product-page price.

How we verified this

• Read the programme pages first and confirmed no figure appears on any of them.
• Took only the table row that names this seller, and left every market figure in the same table unrecorded.
• Recorded the bottom of the published range with the top of it named in the qualifier, rather than averaging the two.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand against the live federal warning-letter table, filtering locally because the table's own search parameter returns every record whatever is typed into it, with a positive and a nonsense control in the same run.